Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 239-594-3
CAS number: 15546-11-9
The following key studies were submitted to fulfil the acute toxicity data requirement:Oral:In an acute oral toxicity study equivalent to OECD Guideline No. 401, groups of 10 young adult Sprague-Dawley rats/sex were given a single oral dose of the test item Prosper MSL (96 % Methyl-(Z,Z)-8,8-dibutyl-3,6,10-trioxo-2,7,9-trioxa-8-stannatrideca-4,11-dien-13-oat) in vegetable oil at doses of 0 (vehicle control), 100, 200, 400, 800, and 1600 mg/kg bw and observed for 14 days.Oral LD50 Females: 419 mg/kg bw (95% C.L. 229.78 to 764.46 mg/kg bw)Oral LD50 Males: 526 mg/kg bw (95% C.L. 319.59 to 866.74 mg/kg bw)Treatment related clinical signs were lethargy, motor incoordination, altered faeces consistency, nosebleeding and body weight retardation. There were no treatment related necropsy findings in animals found dead within the observation period or sacrificed at study termination.Methyl-(Z,Z)-8,8-dibutyl-3,6,10-trioxo-2,7,9-trioxa-8-stannatrideca-4,11-dien-13-oat is of moderate toxicity based on the oral LD50 of 526 and 419 mg/kg bw in male and female rats, respectively.Dermal:The acute dermal LD50 of the test material is in the range of 5000 mg/kg bw, as within one week of observation 3/5 males and 2/5 females died after application of this dose, whereas none of the animals treated with 2500 mg/kg bw . The whole treated area of the skin became necrotic and started to slough off seven days after the application of the test material. To avoid unnecessary suffering the experiment was therefore terminated after one instead of two weeks. After treatment a heavy weight loss was also observed.Inhalation: As the substance is known to be corrosive to the skin, it is considered justified to omit further testing in the interest of animal welfare.
The Manzo, 1991 study is considered to be the key endpoint for acute
oral toxicity as the study seems comparable to the OECD 401 guideline
study with acceptable restrictions, however there is no data regarding
GLP and has therefore been assigned a Klimisch score of 2. This study is
the most recent study available and is also gives the lowest LD50 of the
studies and so has been used for classification purposes.
The acute lethal dose (LD50) and 95%
confidence limits for dibutyltin methyl maleate were reported as:
Males: 526 (319.59 to 866.74) mg/kg bw
Females: 419 (229.78 to 764.46) mg/kg bw
Supporting information is also available from a summary report for oral
toxicity (Davies & Lloyd, 1975). This has been assigned a Klimisch
rating of 4 as this is a summary report with very limited information on
methods, also there are no deatil regarding purity and it predates GLP.
Result: LD50 1.0 ml/kg (equivalent to 1380 mg/kg)
The Sarasin, 1981 study is considered to be the key endpoint for acute
dermal toxicity as the study seems comparable to guideline study with
acceptable restrictions, however there is no data regarding purity and
GLP and has therefore been assigned a Klimisch score of 2.
Inhalation: As the substance is known to be corrosive to the skin, it is
considered justified to omit further testing in the interest of animal
According to the criteria set out in Directive 67/548/EEC, the test
material is classified with R22; Harmful if swallowed, and as Acute
Category 4; H302: Harmful if swallowed, according to Regulation (EC) No
The key parameter chosen for acute toxicity for the dermal route is
greater than the criteria set out in Directive 67/548/EEC and also
Regulation (EC) No 1272/2008, therefore classification for acute dermal
toxicity is not considered to be necessary.
Inhalation: Further testing for this endpoint is considered uneccessary,
as the substance is classified as corrosive.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again